Completed NA INTERVENTIONAL 2-arm NCT01731782

Evaluation of a TAP Block Given During Laparoscopic Colorectal Surgery to Help Control Pain (TAP Block)

Evaluation of a TAP Block as Part of an Enhanced Recovery Pathway in Laparoscopic Colorectal Surgery: A Prospective, Randomized, Double-blinded Multi-institution Trial

Sponsor: University Hospitals Cleveland Medical Center

Conditions Colorectal Disease

Interventions bupivacaine normal saline placebo (for bupivacaine)

Updated 7 times since 2017 Last updated: Oct 11, 2022 Started: Jul 31, 2012 Primary completion: Aug 31, 2014 Completion: Aug 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01731782, this NA trial focuses on Colorectal Disease and remains completed. Sponsored by University Hospitals Cleveland Medical Center, it has been updated 7 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Jan 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jul 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospitals Cleveland Medical Center

Data source: University Hospitals Cleveland Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cleveland, United States